Titlebook: Current Cancer Therapeutics; John M. Kirkwood,Michael T. Lotze,Joyce M. Yasko Book 2001Latest edition Springer Science+Business Media New

只看該作者 · 發(fā)表于 2025-3-21 16:40:55

書(shū)目名稱Current Cancer Therapeutics影響因子(影響力)

書(shū)目名稱Current Cancer Therapeutics影響因子(影響力)學(xué)科排名

書(shū)目名稱Current Cancer Therapeutics網(wǎng)絡(luò)公開(kāi)度

書(shū)目名稱Current Cancer Therapeutics網(wǎng)絡(luò)公開(kāi)度學(xué)科排名

書(shū)目名稱Current Cancer Therapeutics被引頻次

書(shū)目名稱Current Cancer Therapeutics被引頻次學(xué)科排名

書(shū)目名稱Current Cancer Therapeutics年度引用

書(shū)目名稱Current Cancer Therapeutics年度引用學(xué)科排名

書(shū)目名稱Current Cancer Therapeutics讀者反饋

書(shū)目名稱Current Cancer Therapeutics讀者反饋學(xué)科排名

只看該作者 · 發(fā)表于 2025-3-22 00:02:50

只看該作者 · 發(fā)表于 2025-3-22 02:56:47

只看該作者 · 發(fā)表于 2025-3-22 07:32:20

Wireless Sensor Networks Essentials The incidence of melanoma has risen more rapidly than any other solid tumor. Approximately 45,000 patients develop melanoma annually, with one in 75 white patients expected to be at risk for developing melanoma in their lifetime at the beginning of this millennium [1]. Interestingly, the increase a

只看該作者 · 發(fā)表于 2025-3-22 12:16:13

Biologic Agentsstim). Although they do not have direct antitumor activity, these recombinant proteins blunt chemotherapy-induced myelopoietic toxicity, and have become useful adjuvants to bone marrow transplantation and aggressive chemotherapeutic regimens.

只看該作者 · 發(fā)表于 2025-3-22 12:55:10

Lung Cancerh previous chemotherapeutic approaches [2]. A small minority of patients, between 15% and 25%, with advanced regional disease stage III with either small cell lung cancer (SCLC) or non-small cell lung cancer (NSCLC) may be cured with intensive combined-modality approaches. Surgery cures 10% to 80% o

只看該作者 · 發(fā)表于 2025-3-22 20:13:56

Melanoma and Other Tumors of the Skin The incidence of melanoma has risen more rapidly than any other solid tumor. Approximately 45,000 patients develop melanoma annually, with one in 75 white patients expected to be at risk for developing melanoma in their lifetime at the beginning of this millennium [1]. Interestingly, the increase a

只看該作者 · 發(fā)表于 2025-3-22 23:31:08

只看該作者 · 發(fā)表于 2025-3-23 03:42:09

978-1-57340-176-0Springer Science+Business Media New York 2001

只看該作者 · 發(fā)表于 2025-3-23 07:34:25

		自動(dòng)登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛(ài)論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點(diǎn)評(píng)	投稿經(jīng)驗(yàn)總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機(jī)版\|小黑屋\| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-30 00:17
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved